Trial of Qui Tam actions involving Amgen Inc. in Massachusetts
will start on October 3, 2011, according to the Company’s
August 8, 2011, Form 10-Q filing with the U.S. Securities and
Exchange Commission for the quarter ended June 30, 2011.
provides in-depth news coverage of pending and recently settled lawsuits involving public companies with assets of USD $1 billion or more. Covered litigation topics include tax issues, insurance disputes, labor problems, shareholder suits, antitrust suits, product liability suits, toxic torts, personal injury suits, among others.